← Back to Search

Enhanced Breastfeeding Support for Increasing Duration

N/A
Waitlist Available
Led By Yukiko Washio, PhD
Research Sponsored by RTI International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
mothers must be at least 18 years old
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether adding monthly financial incentives to a standard breastfeeding intervention will improve breastfeeding duration among low-income mothers.

Who is the study for?
The BOOST trial is for new mothers who have started breastfeeding, are at least 18 years old, and understand English at a fifth-grade level. They must be enrolled or eligible for WIC services and plan to stay in the study area for one year postpartum.
What is being tested?
This trial tests if adding monthly financial rewards to standard WIC support and home visits can extend how long low-income moms breastfeed. The goal is to see if this approach leads to fewer baby health problems and saves on healthcare costs.
What are the potential side effects?
Since this trial involves non-medical interventions like financial incentives and support programs, there are no direct medical side effects. However, participants may experience stress or pressure related to meeting breastfeeding goals.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am a mother and I am at least 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of Breastfeeding
Rate of Pumping
Secondary study objectives
Infant weight gain
Number of Emergency room and pediatrician visits

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SC + BFIExperimental Treatment1 Intervention
Participants randomized into SC+BFI will receive the same services as the Standard Care Control (SC) group (standard breastfeeding services from Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) plus monthly home visits that facilitate navigation to as-needed resources and referrals to services that support breastfeeding and problem solving) plus financial incentives contingent on observed breastfeeding.
Group II: SCActive Control1 Intervention
Participants randomized into Standard Care (SC) will receive standard breastfeeding services from Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) plus monthly home visits that facilitate navigation to as-needed resources and referrals to services that support breastfeeding and problem solving.

Find a Location

Who is running the clinical trial?

RTI InternationalLead Sponsor
196 Previous Clinical Trials
819,631 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,039 Previous Clinical Trials
2,671,274 Total Patients Enrolled
Temple UniversityOTHER
315 Previous Clinical Trials
88,733 Total Patients Enrolled
~27 spots leftby Oct 2025